QXT
- Product code
- QXT
- Device name
- Infliximab Test System
- Device class
- Class 2
- 21 CFR
- 21 CFR 862.3115
- Medical specialty
- Clinical Toxicology
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 1
- Summaries archived here
- 0 (direct download)
- 510(k) clearances (all years, FDA)
- 1 (all years; only the last 3 years are listed here)
FDA classification definition
An infliximab test system intended for the measurement of an infliximab as an aid in the management of patients with Crohns disease or ulcerative colitis.
510(k) clearances, last 3 years (1)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| DEN210056 | 2023-09-29 | Procisedx, Inc. | Procise IFX | — |
Official FDA classification page: QXT
Classification and pathway per current FDA publications. Data from openFDA (CC0).